Exact Mass: 366.08304680000003
Exact Mass Matches: 366.08304680000003
Found 132 metabolites which its exact mass value is equals to given mass value 366.08304680000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pachyrrhizone
Theasaponin F1
Theasaponin f1, also known as tcm f1, is a member of the class of compounds known as naphthacenes. Naphthacenes are compounds containing a naphthacene moiety, which is a polyaromatic hydrocarbon made of four linearly fused benzene rings. Theasaponin f1 is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Theasaponin f1 can be found in tea, which makes theasaponin f1 a potential biomarker for the consumption of this food product.
Daphnoretin methyl ether
Daphnoretin methyl ether is a constituent of Ruta graveolens (rue). Constituent of Ruta graveolens (rue)
2-(2-Chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
GKT136901 is a potent, selective and orally active inhibitor of NADPH oxidase (NOX1/4), with Kis of 160 and 165 nM, respectively. GKT136901 is also a selective and direct scavenger of peroxynitrite. GKT136901 can be used for the research of diabetic nephropathy, stroke, and neurodegeneration. GKT136901 also has anti-inflammatory activity[1][2][3].
Pirinixil
Neofolin
(-)-4beta-(2-hydroxyethylsulfanyl)epicatechin|(-)-epicatechin 4-(2-hydroxyethyl)thio ether|epicatechin 4-(2-hydroxyethylthio)ether
C17H18O7S (366.07731980000005)
2-Hydroxy-3,6-bis(4-hydroxyphenyl)-5-acetoxy-1,4-benzoquinone
5-(2-hydroxyethylthio)-(-)-epicatechin
C17H18O7S (366.07731980000005)
2-(2-hydroxyethylthio)-(-)-epicatecin
C17H18O7S (366.07731980000005)
rel-(5R,6S,7S,8R)-8-chloro-5,6,7,8-tetrahydro-5,6,7-trihydroxy-2-[2-(4-methoxyphenyl)ethyl]-4H-1-benzopyran-4-one
cis-4-Decensaeure-p-bromphenacylester|cis-Dec-4-ensaeure-(4-brom-phenacylester)|decen-(4c)-oic acid-(1)-(4-bromo-phenacyl ester)|Decen-(4c)-saeure-(1)-(4-brom-phenacylester)
C18H23BrO3 (366.08304680000003)
2-(1,3-Benzodioxol-5-yl)-5,6-Dimethoxy-4H-furo[2,3-H]-1-benzopyran-4-one|3,4-methylenodioxy-5,6-dimethoxy-[2,3:7,8]-furanoflavone|methylenedioxy-(3,4)-5,6-dimethoxyfurano-(7,8,2,3)-flavone
fluroxypyr-meptyl
C15H21Cl2FN2O3 (366.09131879999995)
CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5185; ORIGINAL_PRECURSOR_SCAN_NO 5184 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5213; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4609; ORIGINAL_PRECURSOR_SCAN_NO 4607 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5197; ORIGINAL_PRECURSOR_SCAN_NO 5195 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5209; ORIGINAL_PRECURSOR_SCAN_NO 5208 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5216; ORIGINAL_PRECURSOR_SCAN_NO 5212
2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane
C15H12F6N2O2 (366.08029239999996)
Pirinixil
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
Benzoic acid, 4,4-(1,4-phenylenedi-2,1-ethynediyl)bis-
4-(4-Chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine
Rhodamine 110
C20H15ClN2O3 (366.07711500000005)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
6β-[2-(4-hydroxy-phenoxy)-acetylamino]-penicillanic acid
DANSYL-L-ASPARTIC ACID DI(CYCLOHEXYLAMMONIUM) SALT
2-(4-CHLOROPHENOXY)-N-(4-ISONICOTINOYLPHENYL)ACETAMIDE
C20H15ClN2O3 (366.07711500000005)
4-[(4-Imidazo[1,2-A]pyridin-3-ylpyrimidin-2-YL)amino]benzenesulfonamide
1-(4-Chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine
C17H19ClN2O3S (366.08048540000004)
(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
N-methyl-4-(4-pyridin-2-ylpiperazin-1-yl)sulfonylthiophene-2-carboxamide
S-(indol-3-ylmethylisothiocyanyl)-L-cysteinylglycine
3,8,10,11,12-Pentahydroxy-1-methyltetracene-2-carboxylic acid
2-[[(2R)-2-amino-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)propanoyl]amino]acetic acid
4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamide
1-(3-Amino-7-methoxy-1-pyrazolo[3,4-b]quinolinyl)-2-(4-chlorophenyl)ethanone
6-(2,3-Dihydro-1,4-benzodioxin-3-yl)-3-(phenoxymethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
1-[2-(4-Chlorophenyl)sulfonylethyl]-1-ethyl-3-phenylurea
C17H19ClN2O3S (366.08048540000004)
1-[3-(Dimethylsulfamoyl)phenyl]-3-[(5-methyl-2-furyl)methyleneamino]thiourea
4-(Dimethylsulfamoyl)benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
N-[5-(2,3-dihydroindol-1-ylsulfonyl)-1,3,4-thiadiazol-2-yl]-3-methylbutanamide
N-[4-[[(4-chlorophenyl)-oxomethyl]amino]phenyl]-2-hydroxybenzamide
C20H15ClN2O3 (366.07711500000005)
Tetracenomycin F1
A tetracenomycin that is 1-methyl-11-oxo-6,11-dihydrotetracene-2-carboxylic acid bearing four hydroxy substituents at positions 3, 8, 10 and 12.
OSS_128167
OSS_128167 is a potent selective sirtuin 6 (SIRT6) inhibitor with IC50s of 89 μM, 1578 μM and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. OSS_128167 has anti-HBV activity that inhibits HBV transcription and replication. OSS_128167 has anti-cancer, anti-inflammation and anti-viral effects[1][2].
SIRT6-IN-2
SIRT6-IN-2 (Compound 5) is a selective SIRT6 inhibitor (IC50: 34 μM). SIRT6-IN-2 increases acetylation of H3K9 and increases glucose uptake in cultured cells. SIRT6-IN-2 also reduces T cell proliferation. SIRT6-IN-2 has immunosuppressive and chemosensitizing effects[1].
(4r,6r,8r,11e)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),11,15,17-tetraene-2,13-dione
(4r,6s,8s,11e)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),11,15,17-tetraene-2,13-dione
16-methoxy-5,7,11,14,18-pentaoxahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁷,²¹]tetracosa-2,4(8),9,15(23),16,19,21-heptaen-24-one
7,15-dihydroxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6,8,10(24),16(23),17,19-hexaen-5-one
(11e)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-9,11,16,18-tetraene-2,13-dione
2-{3,4-dihydroxy-2-[(2-hydroxyethyl)sulfanyl]phenyl}-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C17H18O7S (366.07731980000005)
2,5,8,10'-tetrahydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one
(1ar,2s,7r,7ar)-7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-3,6,7,10'-tetrol
(4s,6r,8r,11e)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),11,15,17-tetraene-2,13-dione
(1r,3r,5r,6s,7s,8s)-6,8-dihydroxy-2',4,4',12-tetraoxaspiro[tetracyclo[5.4.1.0¹,⁷.0³,⁵]dodecane-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9,9',11'-hexaen-11-one
(3r,5z,9z)-13-chloro-7,14,16-trihydroxy-3-methyl-4,7,8,12-tetrahydro-3h-2-benzoxacyclotetradecine-1,11-dione
(1r,4r,6r,8r,9z,11e,15s)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-9,11,16,18-tetraene-2,13-dione
14-(acetyloxy)-3-methyl-9-oxo-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-13-yl acetate
(7ar,8ar,8bs,8cr,9s)-1,6,8c,9-tetrahydroxy-7ah,8ah,8bh,9h,10h-peryleno[1,2-b]oxirene-7,11-dione
(1r,3ar,4s,9br)-7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-1h,2h,3h,4h,9bh-cyclopenta[a]naphthalen-5-one
C18H23BrO3 (366.08304680000003)
2-hydroxy-16,18-dimethoxy-7,9-dioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaene-13,20-dione
(1s,11r,20r)-6,20-dihydroxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),13,15,17(22)-hexaene-8,18-dione
2-{3,4-dihydroxy-5-[(2-hydroxyethyl)sulfanyl]phenyl}-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C17H18O7S (366.07731980000005)
2-(2h-1,3-benzodioxol-5-yl)-5,6-dimethoxyfuro[2,3-h]chromen-4-one
(1s,2r)-2,5,8,10'-tetrahydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one
2-(4-bromophenyl)-2-oxoethyl (4z)-dec-4-enoate
C18H23BrO3 (366.08304680000003)
(1r,2s,12ar,12bs)-1,2,4,9,12a-pentahydroxy-2,12b-dihydro-1h-perylene-3,10-dione
7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-3,6,7,10'-tetrol
3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,13,16(23),17,19-heptaene-5,7,15-triol
13-chloro-5,14,16-trihydroxy-3-methyl-4,5,10,12-tetrahydro-3h-2-benzoxacyclotetradecine-1,11-dione
(3s,5e,9e)-13-chloro-7,14,16-trihydroxy-3-methyl-4,7,8,12-tetrahydro-3h-2-benzoxacyclotetradecine-1,11-dione
9-(2h-1,3-benzodioxol-5-yl)-4,7-dihydroxy-6-methoxy-3h-naphtho[2,3-c]furan-1-one
(1s,2r,4s,12r,15s)-7,15-dihydroxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6,8,10(24),16(23),17,19-hexaen-5-one
11-hydroxy-3,8-dimethoxy-1-methyl-5-oxatetracene-7,10,12-trione
(2r,3r)-2-{3,4-dihydroxy-5-[(2-hydroxyethyl)sulfanyl]phenyl}-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C17H18O7S (366.07731980000005)
(3r,5e,7s,9e)-13-chloro-7,14,16-trihydroxy-3-methyl-4,7,8,12-tetrahydro-3h-2-benzoxacyclotetradecine-1,11-dione
2-(4-bromophenyl)-2-oxoethyl dec-4-enoate
C18H23BrO3 (366.08304680000003)
7-bromo-4,6-dihydroxy-1-isopropyl-3a,8-dimethyl-1h,2h,3h,4h,9bh-cyclopenta[a]naphthalen-5-one
C18H23BrO3 (366.08304680000003)
6,8-dihydroxy-2',4,4',12-tetraoxaspiro[tetracyclo[5.4.1.0¹,⁷.0³,⁵]dodecane-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9,9',11'-hexaen-11-one
(6s,8s)-6,8-dihydroxy-2',4,4',12-tetraoxaspiro[tetracyclo[5.4.1.0¹,⁷.0³,⁵]dodecane-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9,9',11'-hexaen-11-one
2-amino-n-[3-(dichloromethyl)-6,8-dihydroxy-3-methyl-1-oxo-4a,5,6,7-tetrahydro-4h-2-benzopyran-4-yl]propanimidic acid
(2r,3r)-2-{3,4-dihydroxy-2-[(2-hydroxyethyl)sulfanyl]phenyl}-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C17H18O7S (366.07731980000005)